How has been the historical performance of Gujarat Alkalies?
Gujarat Alkalies' historical performance shows fluctuating net sales, peaking at 4,516.50 Cr in Mar'23 and declining to 4,072.91 Cr in Mar'25, with an operating profit of 360.42 Cr in Mar'25. Despite improvements in profit before tax and profit after tax, the consolidated net profit remained negative at -65.12 Cr.
Answer:The historical performance of Gujarat Alkalies shows a fluctuating trend in net sales, with figures reaching 4,072.91 Cr in Mar'25, up from 3,806.63 Cr in Mar'24, but down from 4,516.50 Cr in Mar'23. The total operating income mirrored this trend, reflecting similar values. The company's total expenditure increased to 3,712.49 Cr in Mar'25 from 3,670.60 Cr in Mar'24, leading to an operating profit (PBDIT) of 360.42 Cr, a significant rise from 136.03 Cr in the previous year. However, the profit before tax showed a stark decline to 9.72 Cr in Mar'25 from a loss of 195.88 Cr in Mar'24, while profit after tax improved to 15.82 Cr from a loss of 132.24 Cr. Despite these improvements, the consolidated net profit remained negative at -65.12 Cr in Mar'25, although it was an improvement from -236.84 Cr in Mar'24. The earnings per share (EPS) reflected this trend, showing -8.87 in Mar'25 compared to -32.25 in Mar'24.Breakdown:
Gujarat Alkalies experienced a volatile financial performance over the years, with net sales peaking at 4,516.50 Cr in Mar'23 before declining to 4,072.91 Cr in Mar'25. The total operating income followed a similar pattern, while total expenditure rose, resulting in an operating profit of 360.42 Cr in Mar'25, a notable increase from the previous year. The profit before tax turned positive at 9.72 Cr, contrasting with the significant loss of 195.88 Cr in Mar'24, and profit after tax also improved to 15.82 Cr. However, the consolidated net profit remained negative at -65.12 Cr, despite being less severe than the prior year's loss. The EPS showed a similar recovery trend, moving from -32.25 to -8.87, indicating some operational recovery, although the overall financial health remains challenged.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
